MX344705B - Composicion de aceite de hierbabuena de liberacion controlada en multiples particulas con recubrimienton enterico y metodo relacionados. - Google Patents

Composicion de aceite de hierbabuena de liberacion controlada en multiples particulas con recubrimienton enterico y metodo relacionados.

Info

Publication number
MX344705B
MX344705B MX2015005913A MX2015005913A MX344705B MX 344705 B MX344705 B MX 344705B MX 2015005913 A MX2015005913 A MX 2015005913A MX 2015005913 A MX2015005913 A MX 2015005913A MX 344705 B MX344705 B MX 344705B
Authority
MX
Mexico
Prior art keywords
peppermint oil
controlled release
oil composition
related methods
enteric coated
Prior art date
Application number
MX2015005913A
Other languages
English (en)
Other versions
MX2015005913A (es
Inventor
Shah Syed
Hassan Daniel
Hassan Fred
Original Assignee
Zx Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zx Pharma Llc filed Critical Zx Pharma Llc
Publication of MX2015005913A publication Critical patent/MX2015005913A/es
Publication of MX344705B publication Critical patent/MX344705B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
    • A61K9/5057Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe una composición en múltiples partículas que se forma a partir de una pluralidad de núcleos individuales que incluyen una fase hidrofóbica que contiene el aceite de hierbabuena disperso en un gel a base de celulosa microcristalina y una fase hidrofílica que contiene un hidrogel. Un recubrimiento entérico está sobre los núcleos individuales. La composición en múltiples partículas puede usarse para tratar los trastornos gastrointestinales.
MX2015005913A 2013-04-23 2013-09-23 Composicion de aceite de hierbabuena de liberacion controlada en multiples particulas con recubrimienton enterico y metodo relacionados. MX344705B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361815073P 2013-04-23 2013-04-23
US201361880294P 2013-09-20 2013-09-20
PCT/US2013/000217 WO2014175852A1 (en) 2013-04-23 2013-09-23 Enteric coated multiparticulate controlled release peppermint oil composition and related methods

Publications (2)

Publication Number Publication Date
MX2015005913A MX2015005913A (es) 2015-09-08
MX344705B true MX344705B (es) 2017-01-04

Family

ID=51792243

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015014915A MX2015014915A (es) 2013-04-23 2013-09-23 Composicion multiparticulada con recubrimiento enterico que tiene un subrecubrimiento proteinico.
MX2015005913A MX344705B (es) 2013-04-23 2013-09-23 Composicion de aceite de hierbabuena de liberacion controlada en multiples particulas con recubrimienton enterico y metodo relacionados.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015014915A MX2015014915A (es) 2013-04-23 2013-09-23 Composicion multiparticulada con recubrimiento enterico que tiene un subrecubrimiento proteinico.

Country Status (21)

Country Link
US (7) US8895086B2 (es)
EP (2) EP2872123B1 (es)
JP (3) JP5869735B2 (es)
KR (2) KR101787225B1 (es)
CN (2) CN105142726B (es)
AU (2) AU2013387667B2 (es)
BR (2) BR112015026283B1 (es)
CA (2) CA2909591C (es)
CY (1) CY1121582T1 (es)
DK (1) DK2988824T3 (es)
ES (2) ES2706152T3 (es)
HR (1) HRP20190210T1 (es)
HU (1) HUE042996T2 (es)
LT (1) LT2988824T (es)
MX (2) MX2015014915A (es)
PL (2) PL2988824T3 (es)
PT (2) PT2872123T (es)
RS (1) RS58325B1 (es)
RU (2) RU2647462C2 (es)
SI (1) SI2988824T1 (es)
WO (3) WO2014175917A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
IL312316A (en) 2012-09-26 2024-06-01 Aragon Pharmaceuticals Inc Antiandrogens for the treatment of castration-resistant prostate cancer without metastases
RU2647462C2 (ru) * 2013-04-23 2018-03-15 ЗедЭкс ФАРМА, ЭлЭлСи Композиция, состоящая из множества частиц, покрытых кишечнорастворимой оболочкой и имеющих белковую внутреннюю оболочку
PE20181295A1 (es) 2015-09-01 2018-08-07 First Wave Bio Inc Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
KR20190008265A (ko) 2016-05-06 2019-01-23 피지션즈 씰, 엘엘씨 발레리안 조성물 및 관련 방법
KR102568459B1 (ko) 2016-10-26 2023-08-22 에스엘 주식회사 차량용 램프 제어 장치
CN107049992A (zh) * 2017-05-31 2017-08-18 盛林 一种egcg微丸胶囊及其制备方法
KR20200070334A (ko) 2017-10-16 2020-06-17 아라곤 파마슈티컬스, 인코포레이티드 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐
CN109864982A (zh) * 2019-03-22 2019-06-11 大连医诺生物股份有限公司 表没食子儿茶素没食子酸酯微囊粉及其制备方法
JP2021003024A (ja) * 2019-06-26 2021-01-14 アリメント工業株式会社 徐放性被覆食品粉体集合体及びその製造方法
US20230102999A1 (en) 2020-01-10 2023-03-30 First Wave Bio, Inc. Deuterated niclosamide
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
US20230190684A1 (en) 2020-03-16 2023-06-22 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound
KR102608047B1 (ko) * 2020-12-29 2023-12-01 주식회사 우제아이엠 역류성 식도질환 또는 기능성 소화불량의 예방 또는 개선을 위한 균형영양식품 조성물
WO2022148672A1 (en) * 2021-01-08 2022-07-14 Société des Produits Nestlé S.A. Oral solid cannabinoid oil composition for treating central nervous system disorders

Family Cites Families (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1811777A (en) 1924-06-19 1931-06-23 Howards & Sons Ltd Process for making synthetic menthol
US2366749A (en) 1942-08-29 1945-01-09 Burton T Bush Inc Process for making synthetic menthol
US3515781A (en) 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
JPS521819A (en) 1975-06-05 1977-01-08 Nippon Tokushu Toryo Kk Acoustic lining material for vehicle
US4080552A (en) 1976-09-22 1978-03-21 Facet Enterprises, Inc. Hybrid blocking oscillator for an electromagnetic fuel pump
EP0015334B1 (en) 1977-08-04 1982-05-19 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
JPS61176535A (ja) * 1985-01-31 1986-08-08 Morishita Jintan Kk 腸溶性製剤
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4808413A (en) 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
IT1243193B (it) 1990-08-10 1994-05-24 Medea Res Srl Composizioni farmaceutiche orali a base di melatonina
US5418010A (en) * 1990-10-05 1995-05-23 Griffith Laboratories Worldwide, Inc. Microencapsulation process
US5169754A (en) * 1990-10-31 1992-12-08 Coulter Corporation Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
DE122007000073I1 (de) 1991-05-09 2008-01-31 Neurim Pharma 1991 Melatonin enthaltene Arzneimittel
JP3015607B2 (ja) 1991-10-16 2000-03-06 信越化学工業株式会社 フェロモン製剤を用いた交信撹乱方法
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5397573A (en) 1993-06-04 1995-03-14 The Procter & Gamble Company Laxative compositions
US5417010A (en) * 1993-08-09 1995-05-23 Ecer; Gunes M. Light weight seeding sheet
US5688510A (en) 1993-11-18 1997-11-18 Nippon Shinyaku Co. Ltd. Process for producing stable medicinal composition, and pharmaceutical preparation
US6469044B1 (en) 1995-02-01 2002-10-22 Neurim Pharmaceuticals (1991) Ltd. Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
US5840332A (en) 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
AU7375598A (en) 1997-05-09 1998-11-27 Sage Pharmaceuticals, Inc. Stable oral pharmaceutical dosage forms
JPH1147581A (ja) 1997-07-30 1999-02-23 Takasago Internatl Corp 徐放性カプセル及びその製造方法
FR2771292B1 (fr) 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
US6365185B1 (en) 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
US6673126B2 (en) 1998-05-14 2004-01-06 Seiko Epson Corporation Multiple chamber fabrication equipment for thin film transistors in a display or electronic device
US6328994B1 (en) 1998-05-18 2001-12-11 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
US6602521B1 (en) 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
JP2000247870A (ja) 1999-02-24 2000-09-12 Isp Japan Kk ウィスカー析出が抑制された固形状製剤及びその製造方法
US8545880B2 (en) 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
EP1184038B1 (en) 1999-06-09 2005-12-28 Mochida Pharmaceutical Co., Ltd. System for release in lower digestive tract
NZ517465A (en) 1999-09-02 2003-10-31 Nostrum Pharmaceuticals Inc Controlled release pellet formulation
US6627223B2 (en) 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
US6458384B2 (en) 2000-02-23 2002-10-01 Impetus Ag Pharmaceutical with predetermined activity profile
ES2253147T3 (es) 2000-03-04 2006-06-01 Cognis Ip Management Gmbh Microcapsulas.
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
US6423349B1 (en) 2000-08-24 2002-07-23 Baxter International, Inc. Therapeutic nutrient composition for pre and post elective surgery
GB0025208D0 (en) 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
FR2816507B1 (fr) 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
US20020114832A1 (en) 2000-12-11 2002-08-22 Dr. Willmar Schwabe Gmbh & Co. Pharmaceutical preparation comprising peppermint oil and caraway oil in delayed release form
US20030143272A1 (en) 2001-03-14 2003-07-31 Waterman Kenneth C. Pharmaceutical tablet and process for making thereof
ATE487472T1 (de) 2001-11-22 2010-11-15 Morishita Jintan Co Nicht-gelatinöse kapseln
US20030232839A1 (en) 2002-01-18 2003-12-18 Hypnion, Inc. Treatment of sleeping disorders using CNS sleep target modulators
JP4429590B2 (ja) * 2002-02-08 2010-03-10 株式会社協和ウェルネス ユビキノン含有水可溶性組成物
AU2003220551A1 (en) 2002-03-26 2003-10-13 Euro-Celtique S.A. Sustained-release gel coated compositions
US7115282B2 (en) 2002-04-17 2006-10-03 Salvona Ip Llc Multi component controlled release system for anhydrous cosmetic compositions
US6919348B2 (en) 2002-05-02 2005-07-19 Edward T. Wei Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
DE10224087A1 (de) 2002-05-31 2003-12-11 Symrise Gmbh & Co Kg Kompaktiertes Menthol
US20040062778A1 (en) 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices
DK1545475T3 (da) * 2002-10-01 2014-07-28 Banner Pharmacaps Inc Enterisk sammensætning til fremstillingen af blød kapselvæg
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
AU2003274355A1 (en) 2002-10-24 2004-05-13 Micap Plc. Targeted delivery
EP1556021B1 (en) * 2002-10-24 2007-12-19 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
WO2004086874A1 (en) 2003-03-26 2004-10-14 Wm. Wrigley Jr. Company Confectionery with fast flavor release jacket coating
US6737470B1 (en) 2003-04-04 2004-05-18 Bridgestone Corporation Curable sealant composition
EP1670442A4 (en) * 2003-09-19 2011-09-14 Penwest Pharmaceuticals Co DOSAGE FORMS WITH DELAYED RELEASE
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20050164987A1 (en) 2003-12-24 2005-07-28 Barberich Timothy J. Melatonin combination therapy for improving sleep quality
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
US20050181047A1 (en) 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US20050202079A1 (en) 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
PL1746980T3 (pl) * 2004-05-07 2012-03-30 Nycomed Gmbh Farmaceutyczna postać dawkowania zawierająca peletki i sposób jej wytwarzania
US8383154B2 (en) 2004-05-11 2013-02-26 Egalet A/S Swellable dosage form comprising gellan gum
US20050281876A1 (en) 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
DE102004036437A1 (de) 2004-07-27 2006-03-23 Röhm GmbH & Co. KG Multipartikuläre Arzneiform für wenig lösliche Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
ITMI20041689A1 (it) 2004-09-01 2004-12-02 Bojidar Mihaylov Stankov Nuove formulazioni di rilascio controllato contenenti 5-idrossitriptofano e triptofano
KR20070084325A (ko) * 2004-11-18 2007-08-24 브리스톨-마이어스 스큅 컴퍼니 익사베필론을 포함하는 장용성 코팅된 비드 및 그의 제조방법
US8574544B1 (en) 2005-01-04 2013-11-05 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
US8361439B1 (en) 2005-01-04 2013-01-29 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
US8535640B1 (en) 2005-01-04 2013-09-17 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
US8337811B1 (en) 2005-01-04 2012-12-25 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
JP5282208B2 (ja) 2005-03-16 2013-09-04 シムライズ アーゲー メントール含有固体組成物
US9149439B2 (en) * 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition
CN101111231A (zh) 2005-03-29 2008-01-23 罗姆有限公司 包含具有影响调节物质递送的基质的小丸的多颗粒药用形式
US20060257469A1 (en) 2005-04-05 2006-11-16 Bulka Yochanan R Enhanced indoleamine and catecholamine bio-availability via catechin inhibition of L-Dopa decarboxylase
EP1875911A4 (en) * 2005-04-28 2010-03-03 Eisai R&D Man Co Ltd STABILIZED COMPOSITION
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US20060280795A1 (en) 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
AU2006273842B2 (en) 2005-07-28 2012-02-02 University Of Hull Topical formulations containing sporopollenin
US20070048366A1 (en) 2005-08-26 2007-03-01 Jen-Chi Chen Gelatin-based coatings having improved durability
JP2007197378A (ja) 2006-01-27 2007-08-09 Kowa Co 糖衣製剤
US20070292510A1 (en) * 2006-06-19 2007-12-20 Hugh Huang Enteric coated particles containing an active ingredient
WO2008057802A2 (en) * 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
JP5201819B2 (ja) 2006-11-22 2013-06-05 エスエス製薬株式会社 固形組成物
AR063983A1 (es) 2006-11-28 2009-03-04 Wyeth Corp Formulacion de liberacion controlada de agonistas y antagonistas de piperazina -piperidina del receptor 5-ht1a que tienen una disolucion intestinal mejorada
JP2010510988A (ja) * 2006-11-28 2010-04-08 マリナス ファーマシューティカルズ ナノ粒子製剤とその製造方法およびその利用
US20080139510A1 (en) 2006-12-07 2008-06-12 Abe Rose Treatment of migraine headaches with sublingual amino acids
EP1953625A1 (en) 2007-02-02 2008-08-06 Melik Gencel Peripheral inputting device for computers
ES2575549T3 (es) 2007-04-11 2016-06-29 John A. Mccarty Comprimido de melatonina y métodos de preparación y uso
WO2008134807A1 (en) 2007-05-04 2008-11-13 The University Of Sydney Method for manufacturing a porous polymer matrix
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
US20100261723A1 (en) 2007-07-09 2010-10-14 Astrazeneca Ab Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
US8048921B2 (en) 2007-09-18 2011-11-01 Ronald Kramer Amino acid compounds
EP2205231A1 (en) 2007-10-01 2010-07-14 NeuroSearch A/S Pharmaceutical compositions of 5-hydr0xytrypt0phan and serotonin-enhancing compound
GB0724550D0 (en) * 2007-12-18 2008-01-30 Univ Hull Formulations
US20090238905A1 (en) 2008-03-20 2009-09-24 Symrise, Inc. Inflammation reducing action of synergistic mixtures of bisabolol and ginger extracts
US20090246301A1 (en) * 2008-03-31 2009-10-01 Ehrenpreis Ben Z Method for treating irritable bowel syndrome and other functional gastrointestinal disorders
DE102008023345B4 (de) 2008-05-13 2014-12-04 Lts Lohmann Therapie-Systeme Ag Filmförmige Zubereitung mit öligen Substanzen zur oralen Verabreichung
CN101596166B (zh) 2008-06-04 2011-08-17 永信药品工业(昆山)有限公司 阿司匹林肠溶微丸
AU2009258120B2 (en) * 2008-06-10 2014-11-27 Teva Pharmaceutical Industries, Ltd. Rasagiline soft gelatin capsules
US20110053866A1 (en) 2008-08-12 2011-03-03 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions
US20120128764A1 (en) * 2009-02-23 2012-05-24 Aptalis Pharmatech, Inc. Controlled-release compositions comprising a proton pump inhibitor
EP2437730A4 (en) 2009-05-20 2014-02-26 Lingual Consegna Pty Ltd ORAL AND / OR SUBLINGUAL THERAPEUTIC FORMULATION
EP2305742B1 (en) 2009-10-01 2017-02-22 Symrise AG Spherical core-shell-particle
US9205395B2 (en) 2009-10-15 2015-12-08 Encapsys, Llc Encapsulation
WO2011057206A1 (en) * 2009-11-07 2011-05-12 University Of Iowa Research Foundation Cellulose capsules and methods for making them
WO2011111027A2 (en) 2010-03-11 2011-09-15 Dexcel Pharma Technologies Ltd. Oral dispersible delayed release tablet formulation
WO2011146078A1 (en) 2010-05-21 2011-11-24 Board Of Regents, The University Of Texas System Encapsulated particles for enteric release
JP2010189443A (ja) 2010-06-07 2010-09-02 Ss Pharmaceut Co Ltd 揮散防止型固形製剤およびその製造方法
CN103826614B (zh) 2010-11-16 2018-04-13 普乐维美北美公司 用于呕吐毒素解毒的包肠溶衣的焦亚硫酸钠禽畜饲料添加剂
BE1019142A3 (fr) * 2011-01-21 2012-03-06 Vesale Pharma S A Substance probiotique microencapsulee.
US8568776B2 (en) * 2011-02-11 2013-10-29 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US20120301541A1 (en) 2011-05-24 2012-11-29 Haronsky Elina Compressed core for pharmaceutical composition
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
US20120315337A1 (en) 2011-06-07 2012-12-13 Shah Syed Multiparticulate 5-htp compositions and related methods
WO2012170488A1 (en) 2011-06-07 2012-12-13 Zx Pharma, Llc Multiparticulate s-adenosylmethionine compositions and related methods
DE202012000910U1 (de) * 2012-01-20 2013-01-21 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Systemische Darreichungsformen mit kontrollierter Freisetzung und verbesserter Stabilität
JP6227546B2 (ja) 2012-10-26 2017-11-08 田辺三菱製薬株式会社 メントールウィスカーの析出を抑制する方法
US20140178468A1 (en) 2012-12-24 2014-06-26 Ranbaxy Laboratories Limited Multiparticulate extended-release composition of mesalamine
RU2647462C2 (ru) * 2013-04-23 2018-03-15 ЗедЭкс ФАРМА, ЭлЭлСи Композиция, состоящая из множества частиц, покрытых кишечнорастворимой оболочкой и имеющих белковую внутреннюю оболочку
JP2015024986A (ja) 2013-06-20 2015-02-05 大正製薬株式会社 固形製剤

Also Published As

Publication number Publication date
KR20150042233A (ko) 2015-04-20
AU2013387667A1 (en) 2015-10-29
PT2872123T (pt) 2017-03-15
CA2909591C (en) 2017-03-28
US11826475B2 (en) 2023-11-28
SI2988824T1 (sl) 2019-02-28
CN105142726B (zh) 2020-02-07
KR101787225B1 (ko) 2017-10-18
WO2014175916A1 (en) 2014-10-30
HUE042996T2 (hu) 2019-07-29
CA2909591A1 (en) 2014-10-30
MX2015014915A (es) 2016-03-07
PT2988824T (pt) 2019-01-30
US9572782B2 (en) 2017-02-21
EP2872123A4 (en) 2016-01-20
CA2881992A1 (en) 2014-10-30
WO2014175917A8 (en) 2014-12-18
BR112015026283B1 (pt) 2023-04-25
RU2647462C2 (ru) 2018-03-15
US9717696B2 (en) 2017-08-01
US9192583B2 (en) 2015-11-24
BR112015026283A2 (es) 2017-09-05
US20160022597A1 (en) 2016-01-28
US20140314860A1 (en) 2014-10-23
RU2015149770A (ru) 2017-05-26
EP2872123A1 (en) 2015-05-20
JP6105761B2 (ja) 2017-03-29
WO2014175852A1 (en) 2014-10-30
BR112015006499A2 (pt) 2017-07-04
JP2015534582A (ja) 2015-12-03
AU2013387678B2 (en) 2015-04-16
JP5869735B2 (ja) 2016-02-24
US10420730B2 (en) 2019-09-24
RU2606593C1 (ru) 2017-01-10
KR101616679B1 (ko) 2016-04-28
JP2016056189A (ja) 2016-04-21
MX2015005913A (es) 2015-09-08
KR20150139961A (ko) 2015-12-14
EP2988824B1 (en) 2018-11-07
ES2616701T3 (es) 2017-06-14
US20220071912A1 (en) 2022-03-10
LT2988824T (lt) 2019-02-25
PL2988824T3 (pl) 2019-04-30
CY1121582T1 (el) 2020-05-29
EP2988824A4 (en) 2017-02-01
AU2013387678A1 (en) 2015-02-26
CN105263480A (zh) 2016-01-20
PL2872123T3 (pl) 2017-06-30
US20150044294A1 (en) 2015-02-12
ES2706152T3 (es) 2019-03-27
US20160038429A1 (en) 2016-02-11
US20190307701A1 (en) 2019-10-10
CN105263480B (zh) 2018-08-28
AU2013387667B2 (en) 2016-08-04
US11207273B2 (en) 2021-12-28
EP2988824A1 (en) 2016-03-02
DK2988824T3 (en) 2019-01-14
EP2872123B1 (en) 2017-01-04
HRP20190210T1 (hr) 2019-04-05
WO2014175917A1 (en) 2014-10-30
US8895086B2 (en) 2014-11-25
CN105142726A (zh) 2015-12-09
RS58325B1 (sr) 2019-03-29
JP2016517867A (ja) 2016-06-20
US20150050352A1 (en) 2015-02-19
CA2881992C (en) 2016-11-22

Similar Documents

Publication Publication Date Title
MX2015005913A (es) Composicion de aceite de hierbabuena de liberacion controlada en multiples particulas con recubrimienton enterico y metodo relacionados.
FR22C1013I2 (fr) Dihydronaphtyridines et composés apparentés utiles comme inhibiteurs de kinases pour le traitement de maladies prolifératives
EP3405251A4 (en) SYSTEMS, METHODS AND DEVICES FOR PERIPHERAL NEUROMODULATION FOR THE TREATMENT OF DISEASES RELATED TO BUBBLE HYPERACTIVITY
EP3488406A4 (en) METHOD OF DISTRIBUTING TOKENS AND MANAGING TOKEN RELATIONS
EP3091674A4 (en) Method and mtc device for performing random access procedure according to plurality of parameter sets
EP2986047A4 (en) METHOD AND DEVICE FOR DYNAMICALLY ALLOCATING SPECTRA
SG11201602421VA (en) Inhibitors of bruton's tyrosine kinase
EP4324527A3 (en) Formulations of enzalutamide
EP3019489A4 (en) MODULATORS OF TYROSINE KINASE PROTEIN AND METHODS OF USE
EP3282781A4 (en) Method and device for improving positioning performance of artificial neural network
EP2971004A4 (en) PROCESS FOR MODULATING PLANT SEA AND NECTAR CONTENT
HK1217896A1 (zh) 用於治療廣泛性發展障礙的複合物及方法
IL267405B (en) Coated nanoparticles for use in modulation of electrical polarization of neurons
EP3038634A4 (en) Novel sez6 modulators and methods of use
PT3280392T (pt) Regimes de dosagem de amissulprida para tratamento de náuseas e vómitos
EP3027147A4 (en) ARTIFICIAL DISC DEVICE AND RELATED METHODS OF USE
EP3039022A4 (en) Compositions and methods for the treatment of metabolic and body weight related disorders
EP2899262A4 (en) PREPARATION AND USE OF A NEURONAL NETWORK AND NEURONIC PLANTING DEVICE
EP2970223A4 (en) Novel Modulators of 5-Hydroxypropylamine Receptor 7 Activity and Methods of Use
EP3200589A4 (en) Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
EP3469601A4 (en) HYBRID POLYMER-SILICA PDOTS AND METHOD FOR USE THEREOF
EP3071350A4 (en) Coated casting cores and manufacture methods
GB2538031A (en) Methods of producing particles having two different properties
EP3367536A4 (en) METHOD AND DEVICE FOR ASSIGNING THE EFFICIENCY OF A WIND ENERGY SYSTEM
EP3415864A4 (en) SHAPE MEASURING DEVICE AND METHOD FOR MANUFACTURING AN OBJECT TO BE COATED

Legal Events

Date Code Title Description
FG Grant or registration